| PANACEA BIOTEC              | |
| BOM : 531349     NSE : PANACEABIO     | |
| LT :   
                
                
                                      
                                    
                
                
                    Long Term Analysis  
                     Fundamentals : Bad 
                     Valuation : Bad [Stock is Expensive] Debt : Low | Updated: | 
| ST :   
                  
                  
                  
                       Short Term Analysis   
                       Quarterly Earnings Trend : Upward 
                       Price Momentum : Upward Pledged Shares : None or < 25% | Oct 31,2025 | 
| Price(EOD): ₹ 437.75 
                  
                  
                  This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
                  
                 | Pharmaceuticals & Drugs | 
| MCap: ₹ 2,683.41 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y | 
| PANACEA BIOTEC | -0.1% | 7.7% | 50.3% | 
| SUN PHARMACEUTICAL INDUSTRIES | -0.3% | 6% | -10.5% | 
| DIVIS LABORATORIES | 3.9% | 18.6% | 14.5% | 
| CIPLA | -5.2% | NA | 2.5% | 
| TORRENT PHARMACEUTICALS | -1% | -1.2% | 8.7% | 
| DR REDDYS LABORATORIES | -6.8% | -2.1% | -8.4% | 
| MANKIND PHARMA | -1.4% | -2.2% | 0.7% | 
| ZYDUS LIFESCIENCES | -3.9% | -0.7% | -2% | 
| LUPIN | 2.2% | 2.8% | -11.8% | 
FUNDAMENTAL ANALYSIS OF PANACEA BIOTEC
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF PANACEA BIOTEC
 | Ratio | Consolidated | |
|---|---|---|
| P/E P/B P/S | 241.12 
                      
                      P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 11.12 Cr [Latest Qtr - Jun2025 - Consolidated Results ] 3.21 
                      
                      P/B Calculated based on Book Value of Rs 834.79 Cr  [Latest Year - Mar2025 - Consolidated Results ] 4.39 
                      
                      P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 610.07 Cr  [Latest Qtr - Jun2025 - Consolidated Results ] | |
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) | 
|---|---|
| EV/EBIDTA EV/Sales Price/Sales | NA 44% 211% | 
SHARE PRICE MOMENTUM OF PANACEA BIOTEC
PANACEA BIOTEC vs SENSEX
DEBT OF PANACEA BIOTEC
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
| 2025 2024 2023 Avg_3yrs | 0.73 0.38 0.31 0.47 | 0.03 0.02 0.02 0.02 | 
|  [Last Annual Data : Mar2025]   | ||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF PANACEA BIOTEC
| Pledged Promoter Shares | 0 % | |
|---|---|---|
| As on : Sep2025 | ||
| If less than 25% | Good | |
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF PANACEA BIOTEC
| Consolidated | Q-o-Q | Y-o-Y | 
|---|---|---|
| Revenue Op Profit Profit Before Tax Profit After Tax | 25.78% 95.61% 16500% 299% | 44.05% 91.57% 138.48% 124.94% | 
| QtrlyTrend | 8 | |
| Latest Qtr: Jun2025 | ||
| Quarterly Result Analysis → | ||
PANACEA BIOTEC related INDICES
| BSE Indices | 1W | 1M | 1Y | 
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% | 
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% | 
| BSE SMALLCAP | 0.7% | 3.2% | 2.9% | 
| BSE HEALTHCARE | -0.8% | 3.3% | 4% | 
You may also like the below Video Courses
FAQ about PANACEA BIOTEC
Is PANACEA BIOTEC good for long term investment?
As on Oct 31,2025, the Fundamentals of PANACEA BIOTEC look Poor and hence it may not be good for long term investment ! See Financial Performance of PANACEA BIOTEC . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is PANACEA BIOTEC UnderValued or OverValued?
As on Oct 31,2025, PANACEA BIOTEC is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of PANACEA BIOTEC ?
As on Oct 31,2025, the Intrinsic Value of PANACEA BIOTEC is Rs. 222.84 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. -59.21
Fair Value [Median EV / Sales Model] : Rs. 305.01
Fair Value [Median Price / Sales Model] : Rs. 140.67
Estimated Median Fair Value of PANACEA BIOTEC : Rs. 222.84
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
 
                                     
                                     
                                    